Description
PURCHASE OF BLOOD AND BLOOD BYPRODUCTS
Base award description: PURCHASE OF BLOOD PRODUCTS
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-12+$1,206,777= $1,206,777
- Mod P00042012-10-01+$0= $1,206,777
- Mod P000052013-08-15+$0= $1,206,777
- Mod P000062013-09-25+$0= $1,206,777
- Mod P000072013-10-31+$0= $1,206,777
- Mod P000032014-10-01+$0= $1,206,777
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-12 | +$1,206,777 | $1,206,777 | PURCHASE OF BLOOD PRODUCTS |
| Mod P0004· FUNDING ONLY ACTION | 2012-10-01 | +$0 | $1,206,777 | PURCHASE OF BLOOD AND BLOOD BYPRODUCTS |
| Mod P00005· FUNDING ONLY ACTION | 2013-08-15 | +$0 | $1,206,777 | IGF::CT::IGF PURCHASE OF BLOOD AND BLOOD BYPRODUCTS |
| Mod P00006· FUNDING ONLY ACTION | 2013-09-25 | +$0 | $1,206,777 | PURCHASE OF BLOOD AND BLOOD BYPRODUCTS |
| Mod P00007· FUNDING ONLY ACTION | 2013-10-31 | +$0 | $1,206,777 | PURCHASE OF BLOOD AND BLOOD BYPRODUCTS |
| Mod P00003· EXERCISE AN OPTION | 2014-10-01 | +$0 | $1,206,777 | PURCHASE OF BLOOD AND BLOOD BYPRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI T7GCZWHS2FN9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25016D0093 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA25017J0048 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $28,235 | FY2017 |
| VA25017J0049 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $60,000 | FY2017 |
| VA25017P0213 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q515 · MEDICAL- PATHOLOGY | $409,839 | FY2017 |
| VA25016J0016 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q515 · MEDICAL- PATHOLOGY | $56,576 | FY2016 |
| VA25016J0020 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q515 · MEDICAL- PATHOLOGY | $661 | FY2016 |
Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25016P0864 | MCKESSON CORPORATION | 250-NETWORK CONTRACT OFFICE 10 | $10,571 | FY2016 |
| VA25016P0855 | MCKESSON CORPORATION | 250-NETWORK CONTRACT OFFICE 10 | $10,571 | FY2016 |
| VA25016P0838 | MCKESSON CORPORATION | 250-NETWORK CONTRACT OFFICE 10 | $16,913 | FY2016 |
| VA25016F0788 | CSL BEHRING L.L.C. | 250-NETWORK CONTRACT OFFICE 10 | $10,626 | FY2016 |
| VA25016F0783 | CSL BEHRING L.L.C. | 250-NETWORK CONTRACT OFFICE 10 | $7,279 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA25012D0008_3600 · retrieved 2026-09-26.